Top Tweets for #cmsc17
Drs. Edward Fox, Lori Mayer, and @SKriegerMD discuss #MS patient stories and risks/benefits of DMTs #CMSC17 #CME #CE https://t.co/yT7ejY6tqF
Drs. Edward Fox, Lori Mayer, and @SKriegerMD discuss #MS patient stories and risks/benefits of DMTs #CMSC17 #CME #CE https://t.co/yT7ejY6tqF
What’s the evidence for stopping DMTs in #MultipleSclerosis patients? https://t.co/TKUuIatJi7 #CMSC17
#CMSC17 – Ocrevus Lowers MS Relapse Rates Even Further in Extension Study. Read more >> https://t.co/VkjDhij8zQ
#CMSC17 – Rituxan-treated MS Patients Three Times More Likely to Have Improved Brain Scans. Read more >> https://t.co/UirpWKzPA8
#CMSC17 – Tysabri Improves Mental Outlook for Patients with Secondary Progressive Multiple Sclerosis. Read more >> https://t.co/Stkn5rJ5ih
Patient outcome measures should include patient input, not only reflect what providers feel is important https://t.co/QzwlQ5N2pi #CMSC17
#CMSC17 – Lemtrada’s 2 Year Therapy in RRMS Sustains Efficacy for Over 6 Years Without Additional Treatment. >> https://t.co/8mDRDPtXXZ
#CMSC17 – Many Caregivers of MS Patients Say the Disease Exhausts Them Physically and Emotionally. Read more >> https://t.co/DiJgsOMFy3
#CMSC17 – Physical Activity Halts Depression in Young MS Patients, Canadian Study Shows. Read more >> https://t.co/b4kC4d2vIl
#CMSC17 – Celgene’s Investigational Therapy Ozanimod Safe, Effective in Treating RMS, Clinical Trial Finds. Read >> https://t.co/f3kZBddpN2
#CMSC17 – Rituxan-treated MS Patients Three Times More Likely to Have Improved Brain Scans. Read more >> https://t.co/UirpWKzPA8
#CMSC17 – Review Suggests Certain MS Patient Groups May Discontinue Disease-Modifying Treatments. Read more >> https://t.co/L9abDPvmjr
#CMSC17 – Cladribine Reduced Annual MS Relapse Rate by 55% to 57%, Trials Show. Read more >> https://t.co/1NdtGDAcd7
#CMSC17 - Ocrevus, Progressive MS and Other Research Highlights: Interview with CMSC's Robert Lisak https://t.co/N1vgC59HWo
Review suggests halting therapy may be OK in certain subsets of patients later in the disease course. https://t.co/JLz3pbSLod #CMSC17
#CMSC17 – Ocrevus, Progressive MS and Other Research Highlights: An Interview with CMSC’s… https://t.co/aBDptPTgpq
#CMSC17 – MS Patients Should Contribute to Outcome Measure Development, Study Argues. Read more >> https://t.co/ghf0QQqtux
#CMSC17 – Relapse After First Lemtrada Course No Indication of Poor Long-Term Outcome, Study Finds. Read more >> https://t.co/Pt7BKungDR
Last Seen Hashtags on Sotwe
minichat
Seen from Norway
aigirl
Seen from United States
รับงานชลบุรี(())* filter:videos
Seen from Thailand
snapchat
Seen from United States
xlii or #exny or #nolimit() +filter:native_video
Seen from Turkey
شروق_صن_شاين
Seen from Germany
chilena #arsmate
Seen from Chile
ensestpaylasım
Seen from Germany
ukleaks
Seen from Pakistan
روووووووووتانا_تحححححتففففففي_بالوووووطنننن
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.4M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
83.9M followers
Lady Gaga
@ladygaga
75.4M followers
Virat Kohli
@imvkohli
73.3M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.3M followers
Bill Gates
@billgates
65.1M followers
Selena Gomez
@selenagomez
63M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers